December 30, 2025

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a 13% Upside Potential in the Diagnostics Sector

NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the healthcare sector, particularly in diagnostics and research, is capturing investor attention with its potential upside of 13.31%. This Florida-headquartered company, with..

Integra LifeSciences Holdings C (IART) Stock Analysis: Unpacking a 22.92% Potential Upside in the Medical Devices Sector

For investors eyeing opportunities in the healthcare sector, Integra LifeSciences Holdings Corporation (NASDAQ: IART) presents an intriguing proposition. As a key player in the medical devices industry, Integra offers a..

Novavax, Inc. (NVAX) Stock Analysis: Navigating the 87% Potential Upside Amidst Biotech Volatility

Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, continues to attract attention with its innovative vaccine solutions. With a market capitalization of $1.11 billion, the Gaithersburg, Maryland-based..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 38% Upside Potential in the Biotech Sector

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is capturing significant attention from investors, thanks to its promising clinical-stage developments and a substantial market cap of $2.91 billion. As a player in the..

Harrow, Inc. (HROW) Stock Analysis: A Promising 39% Upside Potential in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector may want to consider Harrow, Inc. (NASDAQ: HROW), a dynamic player in the ophthalmic pharmaceutical industry. Currently priced at $50.76, Harrow’s stock has..

Dynavax Technologies (DVAX) Investor Outlook: Analyzing a 33% Potential Upside in the Biopharma Sector

Dynavax Technologies Corporation (NASDAQ: DVAX), a key player in the healthcare sector, is making waves with its promising vaccine developments and a notable 33.38% potential upside, according to analyst ratings...

The Pennant Group, Inc. (PNTG): Investor Outlook with a 24.30% Upside Potential

The Pennant Group, Inc. (NASDAQ: PNTG) is capturing the attention of individual investors, particularly those with an interest in the healthcare sector. With its current market position and significant growth..

Aveanna Healthcare Holdings Inc (AVAH): Investor Outlook with a Promising 27.39% Upside Potential

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) is capturing investor attention with its robust growth trajectory and compelling potential upside of 27.39%, as indicated by current analyst ratings. As a leading..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating a Complex Market with a 7.47% Potential Upside

10x Genomics, Inc. (NASDAQ: TXG), a key player in the healthcare sector, specializes in health information services, offering innovative solutions for analyzing biological systems. Headquartered in Pleasanton, California, this life..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: A Biotech Contender with a 4.89% Upside

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is making waves in the biotechnology sector with its focus on developing therapies for autoimmune diseases. With a market capitalization of $2.09 billion, this Canadian..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A 10.73% Potential Upside Amidst Robust Revenue Growth

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is capturing attention in the biotechnology sector with its promising developments in dermatological disease treatments. Headquartered in Westlake Village, California, this biopharmaceutical company is advancing..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: A Prescription for Growth with 9.75% Upside Potential

Guardian Pharmacy Services, Inc (NASDAQ: GRDN), a prominent player in the healthcare sector, is gaining investor attention with its specialized services in medical care facilities across the United States. With..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a 49.59% Upside Potential

Astrana Health Inc. (ASTH), a prominent player in the healthcare sector, is worth a close look by investors seeking opportunities in the medical care facilities industry. With a market capitalization..

Neogen Corporation (NEOG) Stock Analysis: Evaluating the 13% Upside Potential

Neogen Corporation (NASDAQ: NEOG) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Lansing, Michigan, Neogen has carved out a niche..

Evolent Health, Inc. (EVH) Stock Analysis: Evaluating a Promising 150% Potential Upside

Evolent Health, Inc. (NASDAQ: EVH) stands out in the healthcare sector, particularly within the health information services industry, as a company with a compelling narrative for investors seeking growth opportunities...

Vericel Corporation (VCEL) Stock Analysis: Exploring a 46% Upside Potential in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL), a key player in the biotechnology sector, is drawing significant attention from investors, thanks to its robust product lineup and promising market position. Specializing in cellular..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 14% Potential Upside in Non-Opioid Pain Management

Pacira BioSciences, Inc. (NASDAQ: PCRX) occupies a unique niche within the healthcare sector, focusing on the development and distribution of non-opioid pain management solutions. With a market capitalization of $1.17..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Exploring a 9.25% Upside Potential in the Healthcare Sector

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a leader in the medical devices industry, is gaining attention from investors for its innovative approach to aesthetic and reconstructive plastic surgeries. With its..

Clover Health Investments (CLOV): A 30% Upside Potential Amidst Revenue Growth and Market Volatility

Clover Health Investments, Corp. (NASDAQ: CLOV) is drawing attention in the healthcare sector with its notable 30.38% potential upside, as indicated by the average analyst target price of $3.23. Despite..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Uncovering the 76.93% Upside Potential for Investors

Wave Life Sciences Ltd. (WVE), a pioneering biotechnology company headquartered in Singapore, is captivating the attention of investors with its promising 76.93% potential upside. As a key player in the..

Search

Funds

December 30, 2025

Search

Funds

December 30, 2025

FTSE 100

Funds